Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents by Vito D’Agnano, Fabio Perrotta, Ramona Fomez, Valerio Maria Carrozzo, Angela Schiattarella, Stefano Sanduzzi Zamparelli, Raffaella Pagliaro, Andrea Bianco, Domenica Francesca Mariniello

Subjects: Get full text

Treatment patterns and clinical profile in progressive pulmonary fibrosis: a Japanese cross-sectional survey by Hidekata Yasuoka, Yuko Waseda, Yuko Kaneko, Masateru Okazaki, Ryoko Iwasaki, Shoko Nagata, Mark Small, Haruyuki Ishii

Subjects: Get full text

Therapeutic Potential of Centella asiatica Linn in Oral Submucous Fibrosis: A Short Communication by Pallavi Prakash Channe, Avinash Kharat

Subjects: “…antifibrotic drug…”
Get full text

Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction by Pasquale Tondo, Giulia Scioscia, Cosimo C. De Pace, Fabiola Murgolo, Federica Maci, Giulia M. Stella, Dalila Pescatore, Maria Pia Foschino Barbaro, Donato Lacedonia

Subjects: Get full text

Antihypertrophic effects of the seed ethanolic extract of Aframomum pruinosum Gagnep. (Zingiberaceae) against isoproterenol-induced cardiac hypertrophy in male Wistar rat by Ariane Falone Goumtsa, Elvine Pami Nguelefack-Mbuyo, Florence Nokam, Cédric Wamba Koho, Cherif Mouhamed Moustapha Dial, Télesphore Benoît Nguelefack

Subjects: Get full text

Updates in the management of connective tissue disease-associated interstitial lung disease by Chengappa Kavadichanda, G S R S N K Naidu

Subjects: “…antifibrotic…”
Get full text

Antifibrotic Drug Delivery for Glaucoma Treatment – Determination of Josamycin in vivo by Eickner Thomas, Huling Jennifer, Oschatz Stefan, Lange Helge, Peil Anita, Undre Nasrullah, Stachs Oliver, Stahnke Thomas, Grabow Niels, Jünemann Anselm, Fuellen Georg

Subjects: Get full text

Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis by Vinod K. Viswanathan, Aloke G. Ghoshal, Anant Mohan, Ketaki Patil, Chaitanya Bhargave, Sanjay Choudhari, Suyog Mehta

Subjects: Get full text

Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signalling by B. Reilly-O’Donnell, E. Ferraro, R. Tikhomirov, R. Nunez-Toldra, A. Shchendrygina, L. Patel, Y. Wu, A. L. Mitchell, A. Endo, L. Adorini, R. A. Chowdhury, P. K. Srivastava, F. S. Ng, C. Terracciano, C. Williamson, J. Gorelik

Subjects: Get full text

Tenascin C-Guided Nanosystem for Precision Delivery of Obeticholic Acid in Liver Fibrosis Therapy by Yawen Wang, Lei Yang, Qing Xu, Taiyu Liu, Hongliang He, Lisha Liu, Lifang Yin

Subjects: “…antifibrotic nanomedicine…”
Get full text

Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances by Liangtao Zhao, Haolan Tang, Zhangjun Cheng

Subjects: Get full text

Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis by Mark L. Wencel, Tmirah Haselkorn, Susan L. Limb, John L. Stauffer, Elizabeth Morgenthien, Karina Raimundo, Peter P. LaCamera

Subjects: Get full text

Newer insights into the management of interstitial lung disease in systemic sclerosis by Robert L Mango, Jay H Ryu, Ashima Makol

Subjects: “…Antifibrotic treatment…”
Get full text

The using of genetic markers as a possibility of predicting the rate of progress of liver fibrosis in patients with chronic hepatitis B by К.М. Usychenko

Subjects: Get full text